Literature DB >> 29959024

Determining Performance Metrics for Targeted Next-Generation Sequencing Panels Using Reference Materials.

Megan H Cleveland1, Justin M Zook2, Marc Salit3, Peter M Vallone2.   

Abstract

The National Institute of Standards and Technology has developed reference materials for five human genomes. DNA aliquots are available for purchase, and the data, analyses, and high-confidence small variant and homozygous reference calls are freely available on the web. These reference materials are useful for evaluating whole-genome sequencing methods and also can be used to benchmark targeted sequencing panels, which are used commonly in clinical settings. This article describes how to use the Genome in a Bottle samples to obtain performance metrics on any germline-targeted sequencing panel of interest, as well as the limitations of the reference materials. These materials are useful for understanding the limitations of, and optimizing, targeted sequencing panels and associated bioinformatics pipelines. Example figures are presented to illustrate ways to access the performance metrics of targeted sequencing panels, and a table of best practices is included.
Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29959024      PMCID: PMC6172655          DOI: 10.1016/j.jmoldx.2018.04.005

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  18 in total

1.  Extensive sequencing of seven human genomes to characterize benchmark reference materials.

Authors:  Justin M Zook; David Catoe; Jennifer McDaniel; Lindsay Vang; Noah Spies; Arend Sidow; Ziming Weng; Yuling Liu; Christopher E Mason; Noah Alexander; Elizabeth Henaff; Alexa B R McIntyre; Dhruva Chandramohan; Feng Chen; Erich Jaeger; Ali Moshrefi; Khoa Pham; William Stedman; Tiffany Liang; Michael Saghbini; Zeljko Dzakula; Alex Hastie; Han Cao; Gintaras Deikus; Eric Schadt; Robert Sebra; Ali Bashir; Rebecca M Truty; Christopher C Chang; Natali Gulbahce; Keyan Zhao; Srinka Ghosh; Fiona Hyland; Yutao Fu; Mark Chaisson; Chunlin Xiao; Jonathan Trow; Stephen T Sherry; Alexander W Zaranek; Madeleine Ball; Jason Bobe; Preston Estep; George M Church; Patrick Marks; Sofia Kyriazopoulou-Panagiotopoulou; Grace X Y Zheng; Michael Schnall-Levin; Heather S Ordonez; Patrice A Mudivarti; Kristina Giorda; Ying Sheng; Karoline Bjarnesdatter Rypdal; Marc Salit
Journal:  Sci Data       Date:  2016-06-07       Impact factor: 6.444

Review 2.  Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.

Authors:  Lawrence J Jennings; Maria E Arcila; Christopher Corless; Suzanne Kamel-Reid; Ira M Lubin; John Pfeifer; Robyn L Temple-Smolkin; Karl V Voelkerding; Marina N Nikiforova
Journal:  J Mol Diagn       Date:  2017-03-21       Impact factor: 5.568

Review 3.  Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists.

Authors:  Somak Roy; Christopher Coldren; Arivarasan Karunamurthy; Nefize S Kip; Eric W Klee; Stephen E Lincoln; Annette Leon; Mrudula Pullambhatla; Robyn L Temple-Smolkin; Karl V Voelkerding; Chen Wang; Alexis B Carter
Journal:  J Mol Diagn       Date:  2017-11-21       Impact factor: 5.568

4.  Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.

Authors:  Wenbo Mu; Hsiao-Mei Lu; Jefferey Chen; Shuwei Li; Aaron M Elliott
Journal:  J Mol Diagn       Date:  2016-10-06       Impact factor: 5.568

5.  ACMG clinical laboratory standards for next-generation sequencing.

Authors:  Heidi L Rehm; Sherri J Bale; Pinar Bayrak-Toydemir; Jonathan S Berg; Kerry K Brown; Joshua L Deignan; Michael J Friez; Birgit H Funke; Madhuri R Hegde; Elaine Lyon
Journal:  Genet Med       Date:  2013-07-25       Impact factor: 8.822

6.  Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort.

Authors:  Stefanie Eggers; Simon Sadedin; Jocelyn A van den Bergen; Gorjana Robevska; Thomas Ohnesorg; Jacqueline Hewitt; Luke Lambeth; Aurore Bouty; Ingrid M Knarston; Tiong Yang Tan; Fergus Cameron; George Werther; John Hutson; Michele O'Connell; Sonia R Grover; Yves Heloury; Margaret Zacharin; Philip Bergman; Chris Kimber; Justin Brown; Nathalie Webb; Matthew F Hunter; Shubha Srinivasan; Angela Titmuss; Charles F Verge; David Mowat; Grahame Smith; Janine Smith; Lisa Ewans; Carolyn Shalhoub; Patricia Crock; Chris Cowell; Gary M Leong; Makato Ono; Antony R Lafferty; Tony Huynh; Uma Visser; Catherine S Choong; Fiona McKenzie; Nicholas Pachter; Elizabeth M Thompson; Jennifer Couper; Anne Baxendale; Jozef Gecz; Benjamin J Wheeler; Craig Jefferies; Karen MacKenzie; Paul Hofman; Philippa Carter; Richard I King; Csilla Krausz; Conny M A van Ravenswaaij-Arts; Leendert Looijenga; Sten Drop; Stefan Riedl; Martine Cools; Angelika Dawson; Achmad Zulfa Juniarto; Vaman Khadilkar; Anuradha Khadilkar; Vijayalakshmi Bhatia; Vũ Chí Dũng; Irum Atta; Jamal Raza; Nguyen Thi Diem Chi; Tran Kiem Hao; Vincent Harley; Peter Koopman; Garry Warne; Sultana Faradz; Alicia Oshlack; Katie L Ayers; Andrew H Sinclair
Journal:  Genome Biol       Date:  2016-11-29       Impact factor: 13.583

7.  From Wet-Lab to Variations: Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome Sequencing.

Authors:  Steve Laurie; Marcos Fernandez-Callejo; Santiago Marco-Sola; Jean-Remi Trotta; Jordi Camps; Alejandro Chacón; Antonio Espinosa; Marta Gut; Ivo Gut; Simon Heath; Sergi Beltran
Journal:  Hum Mutat       Date:  2016-09-26       Impact factor: 4.878

8.  Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.

Authors:  Ebun Omoyinmi; Ariane Standing; Annette Keylock; Fiona Price-Kuehne; Sonia Melo Gomes; Dorota Rowczenio; Sira Nanthapisal; Thomas Cullup; Rodney Nyanhete; Emma Ashton; Claire Murphy; Megan Clarke; Helena Ahlfors; Lucy Jenkins; Kimberly Gilmour; Despina Eleftheriou; Helen J Lachmann; Philip N Hawkins; Nigel Klein; Paul A Brogan
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

9.  Variant detection sensitivity and biases in whole genome and exome sequencing.

Authors:  Alison M Meynert; Morad Ansari; David R FitzPatrick; Martin S Taylor
Journal:  BMC Bioinformatics       Date:  2014-07-19       Impact factor: 3.169

10.  Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia.

Authors:  Zafar Iqbal; Siri L Rydning; Iselin M Wedding; Jeanette Koht; Lasse Pihlstrøm; Aina H Rengmark; Sandra P Henriksen; Chantal M E Tallaksen; Mathias Toft
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more
  1 in total

Review 1.  Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease.

Authors:  Thomas I Hewat; Matthew B Johnson; Sarah E Flanagan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.